pioglitazone has been researched along with Cancer of Stomach in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Records from 357 gastric cancer and 1,428 selected matched controls were included in the analyses of gastric cancer risk." | 1.39 | Association of thiazolidinediones with gastric cancer in type 2 diabetes mellitus: a population-based case-control study. ( Chang, SS; Hu, HY, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, SS | 1 |
| Hu, HY | 1 |
1 other study available for pioglitazone and Cancer of Stomach
| Article | Year |
|---|---|
Association of thiazolidinediones with gastric cancer in type 2 diabetes mellitus: a population-based case-control study.
Topics: Adult; Aged; Case-Control Studies; Comorbidity; Diabetes Mellitus, Type 2; Female; Humans; Hypoglyce | 2013 |